GI
TNXP icon

GAMMA Investing’s Tonix Pharmaceuticals TNXP Stock Holding History

GAMMA Investing’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67K Buy
288
+4
+1% +$52 ﹤0.01% 3598
2026
Q1 		$3.9K Buy
+284
New +$4.37K ﹤0.01% 3457

Other funds holding TNXP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return

GAMMA Investing's TNXP Position: Q2 2026 in Review

GAMMA Investing increased its Tonix Pharmaceuticals (TNXP) stake by 1.4% in Q2 2026, buying an estimated $52 and bringing the position to 288 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #3598.

GAMMA Investing first reported a position in TNXP in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.9K in Q1 2026. 6 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • GAMMA Investing held 288 shares of Tonix Pharmaceuticals worth $3.67K as of Q2 2026.
  • GAMMA Investing bought 4 Tonix Pharmaceuticals shares in Q2 2026, an estimated $52.
  • Tonix Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3598 holding.
  • GAMMA Investing first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • GAMMA Investing's Tonix Pharmaceuticals position peaked at $3.9K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.